Clinical Landscape of Multi-Specific Antibodies

Laura von Schantz
Chief Technology Officer
Alligator Bioscience

Barbara Hebeis
Director of Bioassay Development
AstraZeneca
Format: 20 minute presentation followed by 40 minute panel discussion
Register free to attend thought leadership
Do you have a question you’d like Laura von Schantz, Barbara Hebeis to answer during the session?
Register and askRelated posts

Smart Molecules: Harnessing AI and Data to Advance Antibody & Protein Engineering

Computational Methods in Structure Based Biologics Engineering

Clinical Landscape of Multi-Specific Antibodies
Upcoming events
Biologics US 2025
In-Person
Biologics US 2025 brings together leaders in biologics R&D through two focused programs on one dynamic platform. Over two immersive days, the event spotlights breakthrough innovations in proteins, antibodies, and the development of antibody-drug conjugates (ADCs).
Cell 2025
In-Person
Welcome to Cell 2025, Oxford Global’s flagship event, serving as the ultimate meeting place for bioprocessing and advanced therapy professionals. This event brings together leaders from pharma, biotech, academia, and regulatory institutions across the entire cell culture and cell & gene therapy value chain.
Register for free to view
-
Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.
-
From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.
-
Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.
Already registered? Sign In.